Patent · US Active

Polymorphs of Dasatinib, preparation methods and pharmaceutical compositions thereof

US8884013B2 · kind B2 · utility

16Cited by

1References

10Claims

0Family size

Assignees

Nan Jing Cavendish Bio-Engineering Technology Co., Ltd. · CN
Rong Yan · CN

Inventors

Rong Yan · Baoshan, TW
Hao Yang · Shanghai, CN
Yongxiang Xu · 安丰镇, CN

Key dates

Filing date	Jan 31, 2011
Grant date	Nov 11, 2014
Priority date	—
Expiry date	Jan 31, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Polymorph I of dasatinib monohydrate and Polymorph II of dasatinib, their preparation methods and pharmaceutical compositions containing the same are provided. These polymorphs have better physicochemical properties, are more stable and are more suitable for industrial scale production.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.